Johnson & Johnson MedTech (NYSE: JNJ) announced new regulatory nods for multiple orthopedic technology offerings.
Johnson & Johnson reported smaller compensation packages for three top executives and disclosed pay for new medical device leader Tim Schmid.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback